From hidden HIPAA liability to reimbursement cliffs, here's what experienced buyers know before signing on a digital health deal.
Find Vetted Telehealth Platform DealsTelehealth platforms trade at 3.5x–6x revenue, but buyers regularly overpay or inherit catastrophic liability by skipping healthcare-specific diligence. These six mistakes account for the majority of failed or underperforming telehealth acquisitions in the lower middle market.
Market Size
$87 billion globally in 2023, projected to exceed $300 billion by 2030
Growth Trend
Growing
Recession Resistant
Yes
Market Structure
Highly fragmented
Buyers assume HIPAA compliance from a seller's verbal assurance. Unaudited legacy code can harbor serious data security gaps creating OCR investigation exposure and multi-million dollar breach liability post-close.
How to avoid: Require a third-party HIPAA security risk assessment completed within 12 months. Review all BAA agreements and confirm audit logs, encryption standards, and access controls meet current OCR guidance.
Federal telehealth flexibilities granted during COVID-19 face periodic expiration. Revenue built on emergency-use reimbursement codes can evaporate with a single CMS policy change, making historical ARR misleading.
How to avoid: Map every revenue stream to specific CPT and reimbursement codes. Identify what percentage depends on temporary telehealth waivers and model a downside scenario assuming those waivers expire at close.
Many lower middle market telehealth platforms derive 40–60% of revenue from a single health system or employer client. Losing that contract post-acquisition can immediately impair the business's valuation basis.
How to avoid: Require a full customer cohort analysis before LOI. Insist on contract assignment clauses and consider earnout structures that defer payment until key client relationships survive transition under new ownership.
Platforms built with offshore developers or open-source libraries often have incomplete IP assignment agreements. Buyers can acquire a product they don't legally own or that violates licensing terms at scale.
How to avoid: Engage a technical counsel to audit all IP assignment agreements, contractor contracts, and open-source license dependencies before close. Confirm the legal entity owns all proprietary code and clinical algorithms outright.
When payer relationships, provider credentialing, or platform access are tied personally to the founder, transition risk is severe. Buyers often discover this dependency only after the seller has exited.
How to avoid: Require a 6–12 month transition agreement and verify that contracts, provider network agreements, and login credentials are held by the company entity, not the individual founder.
Buyers assume existing EHR integrations are portable and scalable. In reality, custom API builds are often brittle, poorly documented, and require expensive re-engineering when merging with acquirer systems.
How to avoid: Commission a third-party technical architecture review. Request a vendor dependency map and integration documentation. Budget conservatively for re-platforming costs before finalizing your offer price.
Buyers submit SBA loan applications before independently verifying the Telehealth Platform's normalized EBITDA. When diligence reveals add-backs that don't hold, the deal's debt service coverage collapses and the loan fails underwriting.
How to avoid: Build your EBITDA model with conservative add-back assumptions before engaging an SBA lender. At current rates, a $1M SBA 7(a) loan costs approximately $13,000/month — the Telehealth Platform needs $195,000+ in post-salary EBITDA to clear 1.25x DSCR.
Buyers close on a Telehealth Platform assuming operations transfer smoothly, then discover undocumented processes, informal vendor relationships, and staff who rely on institutional knowledge the seller carries in their head.
How to avoid: Require a 60-day operational documentation period before closing. Walk through every key process with the seller present, document staff responsibilities, vendor contacts, and customer communication protocols. Build a 90-day integration plan before the wire hits.
What experienced buyers verify before committing to a Telehealth Platform acquisition.
The specific concerns and miscalculations buyers face in this industry.
Common miscalculations sellers make that reduce their final price or derail a deal.
No. Telehealth platforms are generally not SBA-eligible due to passive income characteristics and healthcare licensing complexity. Most deals are structured with private capital, earnouts, or equity rollovers.
Target platforms with 70% or higher gross margins. Margins below this threshold often signal high provider labor costs, unsustainable reimbursement rates, or significant third-party infrastructure dependency requiring renegotiation.
Map all revenue to specific CPT codes and payer contracts. Identify COVID-era waiver dependencies, review multi-year payer agreements, and consult a healthcare reimbursement attorney to stress-test policy change scenarios.
Earnouts tied to post-close ARR milestones over 12–24 months reduce overpayment risk from reimbursement changes. Equity rollovers of 15–30% with the seller as clinical advisor help preserve provider relationships during transition.
More Telehealth Platform Guides
DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers